The Ipswich Touch Test can take less than a minute, but it can change the trajectory of a high-risk foot. For a Practical Podiatrist Practitioner, the real challenge is not knowing that neuropathy matters, it is fitting reliable screening into a packed clinic while keeping documentation and patient messaging consistent.
Key Takeaways
- Screening is about risk, not labels: The Ipswich Touch Test flags loss of protective sensation, it does not diagnose the cause.
- Technique drives reliability: Consistent touch sites, pressure, and patient setup reduce false positives and false negatives.
- It complements, not replaces, tools: Use it alongside history, inspection, pulses, and (when available) monofilament or vibration.
- Document what you did, not just the result: Site-by-site recording supports continuity and auditability.
- Patient follow-through is the hard part: A simple explanation plus a practical plan improves adherence after a positive screen.
The Ipswich Touch Test: An Essential Neuropathy Screening Tool for Clinicians
The Ipswich Touch Test is a pragmatic bedside screen for loss of protective sensation using light touch to the toes. It was developed as a low-resource alternative when a 10 g monofilament is not available, and it remains useful in real-world settings where time, equipment, or staff training varies.
Clinically, it answers a narrow but crucial question: can the patient reliably perceive light touch at key distal sites? If they cannot, their risk of unnoticed trauma, pressure injury, and ulceration rises. That makes the test especially relevant in diabetes care, but it can also be applied when neuropathy is suspected from other causes (for example, alcohol-related neuropathy, chemotherapy-induced neuropathy, or lumbar radiculopathy), with the same caveat that screening does not equal diagnosis.
Where it fits among neuropathy screening tools
Think of the Ipswich Touch Test as a quick triage tool, not a definitive instrument. In practice, it sits between “no screening” and more formal sensory testing.
A common scenario is a busy nail care or diabetic review clinic where a monofilament has gone missing, or staff rotate and technique variability creeps in. The Ipswich test gives you a standardized fallback that can still be documented.
It also helps bridge clinician and patient behavior. Many patients understand “touch the toes test” faster than they understand vibration thresholds or neuroanatomy, which can make education smoother.
The next step is making sure your technique is consistent, because small variations in contact time, pressure, and patient coaching can change what the result means.
Step-by-Step Guide: How to Perform the Ipswich Touch Test Procedure Correctly
A reproducible Ipswich Touch Test procedure depends on patient setup and a standardized touch sequence. The goal is to minimize cues, avoid pressure that becomes “pain” rather than “touch,” and reduce variability between clinicians.
Patient setup and briefing (keep it short)
Start with a neutral explanation: you will lightly touch some toes; they should say “yes” when they feel it. Ask the patient to close their eyes (or look away) and keep their feet still. In patients with anxiety or cognitive impairment, a brief demonstration on the dorsum of the hand can reduce startle responses without “training” the exact sites.
How to perform Ipswich Touch Test: a practical sequence
Use the pulp of your index finger. Avoid the nail edge. Touch lightly for about 1 to 2 seconds per site, then lift away.
- Position the foot: Support the foot so the toes are relaxed, not dorsiflexed against resistance.
- Select the sites: Common use is the tips of the first, third, and fifth toes on each foot. Some protocols include additional toes, but keep your clinic standard consistent.
- Randomize timing: Add brief pauses and vary the order between feet to reduce guessing.
- Include “sham” moments: Briefly hover without touching once or twice so the patient cannot rely on rhythm.
- Record per site: Mark each site as felt or not felt, rather than only writing “positive” or “negative.”
In our experience, the biggest operator error is pressing too firmly. If you blanch the skin or indent soft tissue, you are no longer testing light touch.
Common pitfalls that inflate false results
Callus and thickened skin can dampen perception, especially at the hallux in patients with high plantar pressures. If the distal pulp is heavily callused, touch an adjacent distal area on the toe pad, still keeping the site consistent with your documentation approach.
Patient cueing is another frequent problem. If you say “ready?” before every touch, you can unintentionally train the patient to respond. Keep your cadence irregular and your voice neutral.
Once you can perform it consistently, the next question clinicians ask is the one that matters for clinical confidence: how accurate is it compared with other tests?
Interpreting Ipswich Touch Test Sensitivity and Specificity: What the Evidence Shows
Ipswich Touch Test sensitivity and specificity are generally reported as clinically useful for screening, with performance that can approach monofilament testing in some studies. The exact numbers vary by study design, reference standard, and population, so interpret them as ranges, not absolutes.
What studies typically compare it against
Most clinical evaluations compare the Ipswich test to established measures such as:
- the 10 g monofilament test (often treated as a practical reference in clinic)
- vibration perception threshold testing (for example, biothesiometer)
- structured neuropathy scoring systems
This matters because the “gold standard test for diabetic neuropathy” depends on what you mean by gold standard. For large-fiber neuropathy, nerve conduction studies are often considered the confirmatory reference, but they are not a point-of-care screen and they do not directly measure protective sensation at the plantar surface.
Ipswich Touch Test vs monofilament: how to think about agreement
Clinically, you are looking for concordance that supports risk stratification. In many outpatient settings, monofilament is treated as the default “diabetic foot test name” patients recognize, while the Ipswich test is a backup or adjunct.
Limitations that clinicians should state out loud
The Ipswich Touch Test does not quantify severity. It is binary at each site: felt or not felt. It also depends on patient attention, language comprehension, and the condition of the skin.
Another limitation is that readers sometimes search for an “Ipswich Touch Test pdf” and adopt a protocol with no training. That can create clinic-to-clinic variability. If you standardize a one-page protocol, pair it with brief competency checks and periodic inter-rater comparison.
Evidence is most useful when it changes workflow. Next, we will plug the Ipswich test into a full foot exam so it supports, rather than interrupts, your usual routine.
Integrating the Ipswich Touch Test into Routine Foot Examination Techniques for Clinicians
The easiest way to embed the Ipswich Touch Test is to anchor it to moments you already have the foot exposed and supported. That usually means after footwear removal and skin inspection, and before you move to offloading, debridement, or orthotic discussion.
A streamlined sequence that works in many clinics is: inspection (skin, nails, interdigital), temperature and edema check, pulses and cap refill, deformity assessment, then Ipswich touch sites, then monofilament or vibration if available.
Documentation is your force multiplier. Build a template line that lists the sites (for example, L1/L3/L5 and R1/R3/R5 toe tips) with felt/not felt entries. Over time, that makes change detection easier, particularly in patients with fluctuating glycemic control.
A common scenario is a patient who “passed” screening last visit but returns with a new blister from tight shoes. If your note shows the exact sites and responses, you can quickly decide whether the screening truly changed, whether callus progressed, or whether the issue was purely mechanical.
Now that the test is part of your flow, the final clinical value comes from what you do with the result.
Post-Test Considerations: Patient Education and Next Steps After Ipswich Touch Test Screening
A positive Ipswich Touch Test is a communication moment. Patients often interpret “reduced sensation” as abstract until you link it to a concrete behavior, like checking inside shoes or avoiding barefoot walking.
If the patient misses one or more sites, explain that their “alarm system” in the foot is quieter. Then give an action plan that is small enough to follow:
Daily visual checks of soles and between toes, plus prompt reporting of any skin break, blister, or color change.
Footwear rules that match their risk, including well-fitting shoes, avoiding heat sources, and using socks that reduce friction.
Follow-up and escalation based on your risk category system (for example, more frequent reviews, callus management, pressure redistribution, and referral pathways).
In practice, patients with neuropathy often also have thickened callus. If you recommend at-home maintenance between visits, be cautious. Mechanical or bladed devices are risky for high-risk feet. If you discuss an electric smoothing device, emphasize conservative use and avoidance in patients with active ulceration, severe neuropathy, or poor vision. Some clinicians reserve these tools for low-risk patients, while prioritizing in-clinic care for those who screen positive.
Frequently Asked Questions About the Ipswich Touch Test
What is the gold standard test for diabetic neuropathy?
There is no single point-of-care “gold standard” for diabetic neuropathy that fits every purpose. Nerve conduction studies are often treated as a confirmatory reference for large-fiber neuropathy, but they are not practical screening tools in routine podiatry visits. In foot risk management, the “gold standard” is often a combination of history, exam, and sensory testing (monofilament, vibration, and simple touch) aimed at identifying loss of protective sensation and ulcer risk.
Is the Ipswich Touch Test the same as the monofilament test?
No, the Ipswich Touch Test and the 10 g monofilament test are different tools that assess similar clinical risk. Monofilament applies a standardized force, while the Ipswich test uses light finger touch at defined toe sites. Many clinicians use the Ipswich test when monofilament is unavailable, or as a quick adjunct. If results conflict with symptoms or ulcer history, confirm with monofilament and vibration testing.
Can patients do the “touch the toes test” at home?
A modified “touch the toes test” can support awareness, but it should not replace clinician screening. Home checks are prone to bias because patients can anticipate touch and may not standardize pressure or sites. If you suggest a partner-assisted check, frame it as a flag for earlier review, not reassurance. Any new blister, cut, or skin color change warrants clinical assessment regardless of perceived sensation.
Putting It Into Practice in Your Next Clinic Session
The Ipswich Touch Test works best when it is routine, documented, and tied to a clear action plan. If you perform it the same way every time, it becomes a reliable signal inside a larger risk assessment, not an isolated data point.
For most clinicians, the biggest win is speed with consistency. A quick touch sequence, recorded per site, makes it easier to justify escalation, reinforce education, and coordinate care across your team.
